Combined Effects of Panipenem and Aminoglycosides on Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa in vitro
- 1 October 2005
- journal article
- research article
- Published by S. Karger AG in Chemotherapy
- Vol. 51 (6) , 387-391
- https://doi.org/10.1159/000088969
Abstract
Background: Methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa are the main causes of refractory infections that are often resistant to antimicrobial agents. In these cases, combination of agents with antimicrobial activity is being examined. However, few studies have investigated combined effects with antimicrobial agents including carbapenem and aminoglycosides. Methods: We evaluated the effects of panipenem (PAPM) combined with 3 aminoglycosides, arbekacin, amikacin, and netilmicin, and vancomicin (VCM) with an agar dilution checkerboard technique and the fractional inhibitory concentration index against 47 strains of MRSA and 56 strains of P. aeruginosa. Results: PAPM combined with VCM achieved a synergic effect against MRSA in 80.9%. PAPM combined with aminoglycosides showed only additive effects against MRSA and P. aeruginosa. When comparing the activity of Mueller-Hinton agar (MHA) medium with MHA medium diluted 40-fold (1/40 MHA) against P. aeruginosa, the mean minimum inhibitory concentration of PAPM was decreased to 1/16. Conclusions: Combination of PAPM and VCM is effective against MRSA. Combinations of PAPM and aminoglycosides showed additive effects against MRSA and P. aeruginosa.Keywords
This publication has 12 references indexed in Scilit:
- Effect of basic amino acids on susceptibility to carbapenems in clinical Pseudomonas aeruginosa isolatesInternational Journal of Medical Microbiology, 2003
- Enhancement of antimicrobial effects of various antibiotics against methicillin-resistant Staphylococcus aureus (MRSA) by combination with fosfomycinJournal of Infection and Chemotherapy, 2003
- Combined effects of meropenem and aminoglycosides on Pseudomonas aeruginosa in vitroJournal of Antimicrobial Chemotherapy, 2000
- Combined effects of vancomycin and imipenem against methicillin-resistant Staphylococcus aureus (MRSA) in vitro and in vivoJournal of Antimicrobial Chemotherapy, 1999
- Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycinThe Lancet, 1997
- F390B and C, new antitumor dihydroxanthone derivatives isolated from Penicillium sp.The Journal of Antibiotics, 1997
- Meropenem Resistance in Pseudomonas aeruginosaChemotherapy, 1996
- In-vitro activities of various antibiotics, alone and in combination with amikacin against Pseudomonas aeruginosaJournal of Antimicrobial Chemotherapy, 1995
- Decreases of the susceptibility to low molecular weightβ-lactam antibiotics in imipenem-resistant Pseudomonas aeruginosa mutants: role of outer membrane protein D2 in their diffusionJournal of Antimicrobial Chemotherapy, 1990
- Bactericidal activity of meropenem and interactions with other antibioticsJournal of Antimicrobial Chemotherapy, 1989